Trump victory elicits fears, some cheers around the globe

November 9, 2016

London, Nov 9: The world faces a starkly different America led by a President Donald Trump.trumpGlb

While the billionaire businessman's election was welcomed in some countries, others saw it as a big shock, as governments will now have to deal with a man who has cozied up to Vladimir Putin, told NATO allies they would have to pay for their own protection and vowed to make the Mexican government pay for a multibillion-dollar border wall.

Trump's win was particularly startling in Mexico, where his remarks calling Mexican immigrants criminals and 'rapists' were a deep insult to national pride. Financial analysts have predicted a Trump win would threaten billions of dollars in cross-border trade, and government officials say they have drawn up a contingency plan for such a scenario, though without releasing details.

"It's DEFCON 2," Mexican analyst Alejandro Hope said. "Probably something as close to a national emergency as Mexico has faced in many decades."

"It depends if he means what he says and if he can do what he claims he wants to do," Hope added. "A massive deportation campaign could really put some stress on Mexican border communities. A renegotiation of NAFTA could seriously hobble the Mexican economy. It could create a lot of uncertainty. ... Financial markets could suffer."

The Mexican peso, which has tracked the U.S. election closely, fell sharply to 20.45 to the dollar late Tuesday before recovering somewhat. The Bank of Mexico's interbank rate had stood at 18.42 at the end of the day's trading.

In Europe, NATO allies now wait to see if Trump follows through on suggestions that America will look at whether they have paid their proper share in considering whether to come to their defense.

Trump's rhetoric has challenged the strategic underpinning of the NATO alliance, rattling its leaders at a time when Russia has been increasingly aggressive.

German Defense Minister Ursula von der Leyen called the vote 'a big shock' and 'a vote against Washington, against the establishment.'

Von der Leyen said on German public Television Wednesday that while many questions remain open, "We Europeans obviously know that as partners in NATO, Donald Trump will naturally ask what 'are you achieving for the alliance,' but we will also ask 'what's your stand toward the alliance.'"

The French populist, anti-immigrant politician Marine Le Pen congratulated Trump even before the final results were known, tweeting her support to the "American people, free!"

Foreign Minister Jean-Marc Ayrault said France would work with the new president and that European politicians should heed the message from Trump votes. "There is a part of our electorate that feels ... 'abandoned,' including people who feel left behind by globalization," he said.

Trump's victory is being viewed with shock and revulsion in Ireland, a country close to the Clintons and fearful of Trump's campaign pledge to confront US companies using Ireland as a tax shelter.

The newspaper of record, the Irish Times, branded the New York businessman a 'misogynistic racist liar' who would fan instability overseas and intolerance at home.

Irish Times columnist Fintan O'Toole wrote Wednesday: "The republic of Washington, Jefferson, Lincoln and Roosevelt is now the United Hates of America."

"President Trump is the creation of the same demographic that gave Europe its far-right authoritarian movements with such disastrous consequences for the world," he wrote. "This does not mean that we are facing an American fascism. But it does mean that Trump will not be able to rule without stoking and manipulating fear."

British Prime Minister Theresa May issued a statement saying she looks forward to working with Trump and building on the two countries' longstanding 'special relationship.' Her predecessor, David Cameron, had been outspoken in his criticism of Trump during the primary campaign.

Nigel Farage, acting leader of the UK Independent Party, which played an important role convincing Britons to leave the European Union, told The Daily Telegraph that Trump's victory would bring a 'massive result' for Britain. A spokesman said Farage - who campaigned briefly with Trump- was flying to Washington Wednesday.

Russian President Vladimir Putin sent Trump a telegram Wednesday morning congratulating him on his victory.

Moscow has been unusually prominent in the race. Clinton's campaign and the Obama administration blamed Russian hackers for leaked emails from the Democratic National Committee and Clinton campaign staff. Trump, in turn, has made complimentary remarks about Putin; the ties some of his advisers and former campaign officials have to Russia have raised suspicions.

"We of course regard with satisfaction that the better candidate of the two presented to the American voters was victorious," said Vladimir Zhirinovsky, leader of Russia's nationalist Liberal Democratic party, according to the Interfax news agency.

In Asia, security issues and trade will top the agenda for the new administration, from North Korea and the South China Sea to the contentious and yet-unratified Trans-Pacific Partnership trade agreement.

Chinese state media and government-backed commentators had signaled Beijing's preference for a Trump win. Like Russia, China is seen as favoring Trump because he appears less willing to confront China's newly robust foreign policy, particularly in the South China Sea.

Clinton, by contrast, is disliked in Beijing for having steered the US 'pivot' to Asia aimed at strengthening US engagement with the region, particularly in the military sphere.

Scholar Mei Xinyu wrote in the Communist Party newspaper Global Times that China would find it easier to cope with a Trump presidency.

"Trump has always insisted on abandoning ideological division and minimizing the risks that unnecessary conflicts with other countries may bring to the U.S.," Mei wrote.

In Indonesia, the world's most populous Muslim country, social media was abuzz with speculation about whether Trump would follow through on campaign rhetoric calling for a ban on Muslims entering the United States. Some said they fear they would be prevented from visiting relatives and friends who live in America or traveling there as tourists.

News of Trump's widening lead hit hard in Cuba, which has spent the last two years negotiating normalization with the United States after more than 50 years of Cold War hostility, setting off a tourism boom. Trump has promised to roll back Obama's opening with Cuba unless President Raul Castro agrees to more political freedoms.

"If he reverses it, it hurts us," taxi driver Oriel Iglesias Garcia said. "You know tourism will go down."

In pubs, bars and restaurants in much of the world, people watched TV and took in the surprise news of Trump's victory.

At a pub in Sydney, Pamela Clark-Pearman, a 63-year-old Clinton supporter, sat nursing a beer.
"I never thought the Americans could be so stupid. I just think it's Brexit all over again,'' Clark-Pearman said, referring to the June 23 British vote to leave the European Union.

Serving the last drinks of the night at a Mexico City tavern where a half-dozen TVs were tuned to election news, bartender Angel Mendoza wondered what will happen to his 15 or so family members living in the United States, about half of whom are there illegally.

"They're not coming here," he said. "Their lives are already made there, but (now) with a certain fear."

Comments

ABD
 - 
Wednesday, 9 Nov 2016

When Authority / Power comes to the hands of unfit person, then wait for the Hour - Muhammad(Pbuh)

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 19,2020

President Donald Trump gave a new justification for killing Qassim Suleimani, telling a gathering of Republican donors that the top Iranian general was "saying bad things about our country" before the strike, which led to his decision to authorise his killing. "How much are we going to listen to?" Trump said on Friday, according to remarks from a fundraiser obtained by CNN.

With his typical dramatic flourish, Trump recounted the scene as he monitored the strikes from the White House Situation Room when Suleimani was killed. The president spoke in a ballroom at his Mar-a-Lago club in Palm Beach, Florida, at a Republican event that raised $10 million for Trump's 2020 campaign.

The January 3 killing of Suleimani prompted Iran to retaliate with missile strikes against US forces in Iraq days later and almost triggered a broad war between the two countries. "They're together sir," Trump said military officials told him. "Sir, they have two minutes and 11 seconds. No emotion. Two minutes and 11 seconds to live, sir. They're in the car, they're in an armoured vehicle. Sir, they have approximately one minute to live, sir. Thirty seconds. Ten, 9, 8 ...'"

"Then all of a sudden, boom," he said. "They're gone, sir. Cutting off, I said, where is this guy?" Trump continued. "That was the last I heard from him". It was the most detailed account that Trump has given of the drone strike, which has drawn criticism from some US lawmakers because neither the president nor his advisers have provided public information to back up their statements that Suleimani presented an "imminent" threat to US.

Trump's comments came a day after he warned Iran's supreme leader Ayatollah Ali Khamenei to be "very careful with his words". According to Trump, Khamenei's speech on Friday, in which he attacked the "vicious" US and described UK, France and Germany as "America's lackeys", was a mistake.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

Jun 2: A new female billionaire has emerged from one of Asia's most-expensive breakups.

Du Weimin, the chairman of Shenzhen Kangtai Biological Products Co., transferred 161.3 million shares of the vaccine maker to his ex-wife, Yuan Liping, according to a May 29 filing, immediately catapulting her into the ranks of the world's richest.

The stock was worth $3.2 billion as of Monday's close.

Yuan, 49 this year, owns the shares directly, but signed an agreement delegating the voting rights to her ex-husband, the filing shows. The Canadian citizen, who resides in Shenzhen, served as a director of Kangtai between May 2011 and August 2018. She's now the vice general manager of subsidiary Beijing Minhai Biotechnology Co. Yuan holds a bachelor's degree in economics from Beijing's University of International Business and Economics.

Kangtai shares have more than doubled in the past year and have continued their ascent since February, when the company announced a plan to develop a vaccine to fight the coronavirus. They slipped for a second day Tuesday following news of the divorce terms, losing 3.1% as of 9:43 a.m. in Hong Kong and bringing the company's market value to $12.9 billion.

Du's net worth has now dropped to about $3.1 billion from $6.5 billion before the split, excluding his pledged shares.

The 56-year-old was born into a farming family in China's Jiangxi province. After studying chemistry in college, he began working in a clinic in 1987 and became a sales manager for a biotech company in 1995, according to the prospectus of Kangtai's 2017 initial public offering. In 2009, Kangtai acquired Minhai, the company Du founded in 2004, and he became the chairman of the combined entity.

China's rapidly growing economy has been an engine for the country's richest, and Du is not the only tycoon who's had to pay a steep price for a divorce. In 2012, Wu Yajun, at one point the nation's richest woman, transferred a stake worth about $2.3 billion to her ex-husband, Cai Kui, who co-founded developer Longfor Group Holdings Ltd. In 2016, tech billionaire Zhou Yahui gave $1.1 billion of shares in his online gaming company, Beijing Kunlun Tech Co., to ex-wife Li Qiong after a civil court settlement.

Sometimes, a goodbye can be time-consuming too. South Korean tycoon Chey Tae-won's wife filed a lawsuit in December asking for a 42.3% stake in SK Holdings Co. valued at $1.2 billion. That would make her the second-largest shareholder of the company should she win the case, which is still ongoing.

The most expensive divorce in history is that of Jeff and MacKenzie Bezos. The Amazon.com Inc. founder gave 4% of the online retailer to Mackenzie, who now has a $48 billion fortune and is the world's fourth-richest woman.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.